Waldenstrom's macroglobulinaemia and Joint swelling

Summary:

Joint swelling is found among people with Waldenstrom's macroglobulinaemia, especially for people who are female, 60+ old.

The study analyzes which people have Joint swelling with Waldenstrom's macroglobulinaemia. It is created by eHealthMe based on reports of 58 people who have Waldenstrom's macroglobulinaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

58 people who have Waldenstrom'S Macroglobulinaemia and Joint Swelling are studied.


What is Waldenstrom's macroglobulinaemia?

Waldenstrom's macroglobulinaemia (cancer affects small lymphocytes (white blood cells)) is found to be associated with 472 drugs and 286 conditions by eHealthMe.

What is Joint swelling?

Joint swelling is found to be associated with 3,172 drugs and 2,710 conditions by eHealthMe.

Number of Joint swelling in Waldenstrom's macroglobulinaemia reports submitted per year:

Would you have Joint swelling when you have Waldenstrom's macroglobulinaemia?

Gender of people who have Waldenstrom'S Macroglobulinaemia and experienced Joint Swelling *:

  • female: 62.5 %
  • male: 37.5 %

Age of people who have Waldenstrom'S Macroglobulinaemia and experienced Joint Swelling *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 6.06 %
  • 60+: 93.94 %

Common co-existing conditions for these people *:

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 7 people, 12.07%
  2. Rashes (redness): 3 people, 5.17%
  3. Pain: 3 people, 5.17%
  4. Nausea (feeling of having an urge to vomit): 3 people, 5.17%
  5. Breakthrough Pain: 3 people, 5.17%
  6. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 3.45%
  7. Neoplasm Malignant (cancer tumour): 2 people, 3.45%
  8. Diabetes: 2 people, 3.45%
  9. Indigestion: 1 person, 1.72%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 1.72%

Common drugs taken by these people *:

  1. Imbruvica: 49 people, 84.48%
  2. Protonix: 8 people, 13.79%
  3. Rituxan: 6 people, 10.34%
  4. Tylenol: 5 people, 8.62%
  5. Eliquis: 5 people, 8.62%
  6. Vitamin D: 4 people, 6.90%
  7. Synthroid: 4 people, 6.90%
  8. Plavix: 4 people, 6.90%
  9. Dexilant: 4 people, 6.90%
  10. Meclizine: 3 people, 5.17%

Common symptoms for these people *:

  1. Peripheral Swelling: 30 people, 51.72%
  2. Head Injury: 19 people, 32.76%
  3. Fatigue (feeling of tiredness): 16 people, 27.59%
  4. Dizziness: 16 people, 27.59%
  5. Headache (pain in head): 15 people, 25.86%
  6. Joint Pain: 15 people, 25.86%
  7. Rashes (redness): 14 people, 24.14%
  8. Muscle Spasms (muscle contraction): 12 people, 20.69%
  9. High Blood Pressure: 11 people, 18.97%
  10. Diarrhea: 11 people, 18.97%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Joint swelling?

Check whether Joint swelling is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Joint swelling:

Common drugs associated with Joint swelling:

All the drugs that are associated with Joint swelling:

Common conditions associated with Joint swelling:

All the conditions that are associated with Joint swelling:

How the study uses the data?

The study is based on Joint swelling and Waldenstrom's macroglobulinaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: